CDC reports more than 5,000 measles cases, highest in 35 years
Trial: heart-scan calcium scores matched standard risk assessment while recommending statins to fewer patients
Bofanglutide–a new GLP-1 drug that can be given once every two weeks or even once a month–has succeeded in a phase 3 trial
STAT investigation: scientists say women seeking "three-parent" IVF have been misled
Lilly says retatrutide beat Novo's Ozempic in a diabetes study
A new oral peptide called Icotrokinra completely cleared psoriasis in 27% of patients after 16 weeks.
We are developing a drug that destroys all known pathogenic bacteria, all known pathogenic fungi, biofilms, influenza virus as well as viruses of the herpes family.
Moderna and Merck say their mRNA melanoma vaccine cut death and recurrence by 42%
Trial: daily vitamin C linked to better survival in precancerous blood disorders
Clinical Trials Article · 9 min read
GLP-1 Drugs: What the Evidence Shows, Organ by Organ
A standing page on the benefits being claimed for GLP-1 drugs beyond weight loss, sorted by how strong the evidence is: four large randomized trials, one mechanism study, two observational signals, and a new preprint that says semaglutide turned back the proteomic age of the heart by 2 to 4 years.
The Librarian · · 0 comments
Clinical Trials Article · 10 min read
The GLP-1 Benefit List Keeps Growing. Here's What's Actually Been Shown.
Semaglutide and tirzepatide keep turning up benefits that have nothing to do with the number on the scale — a kidney, a liver, an airway, even an addiction. Here's what's been shown in a randomized trial, what's still a mechanistic finding from a biopsy, and what's only an observational signal so fa
The Librarian · · 0 comments
Clinical Trials Article · 6 min read
CagriSema vs. Tirzepatide: What the New Diabetes Trial Actually Shows
Novo Nordisk says its experimental drug CagriSema beat Eli Lilly's tirzepatide on weight loss in a head-to-head diabetes trial. It did — against a 5mg dose, not tirzepatide's strongest one. A second trial released the same day, against the 15mg dose, went the other way.
The Librarian · · 0 comments
Clinical Trials Article · 20 min read
Does Red Light Therapy Work, and Why Does the Price Range From $60 to $1,200?
Red light therapy panels run from about $50 for a handheld unit to well over $1,200 for a full-body array, all promising some version of the same benefits. The clinical evidence is genuinely strong for exactly one use case that has nothing to do with a home panel, real but modest for a couple of thi
The Librarian · · 0 comments










